Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Not applicableLooking for participantsNCT01793168What this trial is testingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordWho this might be right forRare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more Sanford Health 20,000
Early research (Phase 1)Study completedNCT00004604What this trial is testingBiological Therapy in Treating Patients With Metastatic CancerWho this might be right forBreast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more Duke University 24
Not applicableNot Yet RecruitingNCT07454486What this trial is testingTRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World CohortWho this might be right forBiliary Tract Cancer (BTC)Biliary Tract Cancer (CCA)Gall Bladder Cancer+11 more Aarhus University Hospital 300
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableStudy completedNCT05147389What this trial is testingArtificial Intelligence for Digital Cholangioscopy Neoplasia DiagnosisWho this might be right forCommon Bile Duct NeoplasmsNon-Neoplastic Bile Duct Disorder Instituto Ecuatoriano de Enfermedades Digestivas 170
Early research (Phase 1)UnknownNCT04660929What this trial is testingCAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsWho this might be right forHER2-positiveAdenocarcinomaBile Duct Cancer+28 more Carisma Therapeutics Inc 48
Not applicableUnknownNCT05374122What this trial is testingAI Guidance for Biopsy in Suspected CholangiocarcinomaWho this might be right forNeoplasmsNon-NeoplasticBile Duct Neoplasms+1 more Instituto Ecuatoriano de Enfermedades Digestivas 48
Not applicableStudy completedNCT04028479What this trial is testingThe Registry of Oncology Outcomes Associated With Testing and TreatmentWho this might be right forAdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more Taproot Health 167
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00066404What this trial is testingIntrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsWho this might be right forCancer Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Looking for participantsNCT05150691What this trial is testingA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsWho this might be right forHER2-positive Advanced Solid Tumor DualityBio Inc. 796
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT00010023What this trial is testingCapecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forCancer NYU Langone Health
Early research (Phase 1)Study completedNCT04853017What this trial is testingELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid TumorsWho this might be right forMinimal Residual DiseaseKRAS G12DKRAS G12R+9 more Elicio Therapeutics 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798